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Abstract: Hydrogen peroxide (H2O2) is an important second messenger in cellular signal 
transduction. H2O2-dependent signalling regulates many cellular processes, such as 
proliferation, differentiation, migration and apoptosis. Nevertheless, H2O2 is an oxidant 
and a major contributor to DNA damage, protein oxidation and lipid peroxidation, which 
can ultimately result in cell death and/or tumourigenesis. For this reason, cells have 
developed complex antioxidant systems to scavenge ROS. Recently, our laboratory 
identified the protein, annexin A2, as a novel cellular redox regulatory protein. Annexin 
A2 possesses a reactive cysteine residue (Cys-8) that is readily oxidized by H2O2 and 
subsequently reduced by the thioredoxin system, thereby enabling annexin A2 to 
participate in multiple redox cycles. Thus, a single molecule of annexin A2 can inactivate 
several molecules of H2O2. In this report, we will review the studies detailing the reactivity 
of annexin A2 thiols and the importance of these reactive cysteine(s) in regulating annexin 
A2 structure and function. We will also focus on the recent reports that establish novel 
functions for annexin A2, namely as a protein reductase and as a cellular redox regulatory 
protein. We will further discuss the importance of annexin A2 redox regulatory function in 
disease, with a particular focus on tumour progression. 
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1. Introduction 
Reactive oxygen species (ROS) are oxygen-containing reactive chemical species, which include 
biologically important molecules, such as superoxide (O2•−), hydroxyl radical (·OH) and hydrogen 
peroxide (H2O2). Until recently, ROS were regarded as harmful by-products of mitochondrial 
respiration, but it is now apparent that the ROS molecule, H2O2, is an important second messenger in 
cellular signal transduction. H2O2 levels are increased by various signalling proteins, including growth 
factors, cytokines, hormones and neurotransmitters through the activation of NADPH oxidase (Nox). 
The increased levels of H2O2 result in the targeting and oxidation of a relatively low abundance 
cysteine thiol residue, called a reactive cysteine residue or thiolate anion. The oxidation of these 
reactive cysteine residues, present in only a selected group of proteins, results in conformational 
changes and thereby regulates the function of the target molecule. Currently, H2O2-dependent signalling 
has been implicated in diverse processes, such as in the regulation of cell proliferation, differentiation, 
migration and apoptosis [1–3]. The production of a cytotoxic molecule has obvious potential risks to 
cells, as H2O2 is the major contributor to DNA damage, protein oxidation and lipid peroxidation that 
ultimately can result in cell death and/or tumourigenesis [4,5]. Cells have developed complex 
antioxidant systems to scavenge ROS. These include proteins, such as catalase, superoxide dismutases, 
glutathione peroxidases and thioredoxin peroxidases. The primary systems that reduce/recycle these 
ROS scavenging proteins are the thioredoxin (Trx) and the glutathione (GSH) systems. 
Several studies have shown an important role for ROS in tumour development [6,7]. Cancer cells 
typically exhibit increased ROS generation compared to normal cell counterparts that not only provide 
cancer cells a proliferative advantage, but also promote malignant progression. In order to balance the 
proliferative advantage of ROS upregulation versus its potential risk due to protein, lipid and DNA 
damage, cancer cells induce the overexpression and/or activation of the cellular antioxidant systems. 
Recently, our laboratory identified a novel cellular redox regulatory protein, called annexin A2, 
which interacts directly with H2O2 molecules in a reversible manner. Annexin A2 possesses an  
N-terminal reactive cysteine residue (Cys-8) that is readily oxidized by H2O2 and subsequently reduced 
by the thioredoxin system, enabling annexin A2 to participate in multiple redox cycles. Thus, a single 
molecule of annexin A2 can inactivate several molecules of H2O2. In summary, we showed that 
annexin A2 played a key role in cellular redox regulation, particularly during oxidative stress  
and tumourigenesis [8]. 
We will critically review the studies detailing the reactivity of annexin A2 thiols and the importance 
of these reactive cysteine(s) in regulating annexin A2 structure and function. We will also focus on the 
recent reports that establish novel functions for annexin A2, namely as a protein reductase and as a 
cellular redox regulatory protein. We will further discuss the importance of annexin A2 redox 
regulatory function in disease, with a particular focus on tumour progression. 
2. Introduction to Reactive Oxygen Species 
Reactive oxygen species (ROS), which include superoxide anion (O2•−), hydrogen peroxide (H2O2) 
and the hydroxyl radical (·OH) exist mainly at low concentrations in the cell (from 10−4 to 10−9 M) and 
are produced as by-products of normal aerobic metabolism by the mitochondria or in response to the 
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activation of certain oxidases, such as NADPH oxidase and xanthine oxidase. These three ROS are 
linked by spontaneous or enzymatic dismutation [9]. Among the different ROS, ·OH is probably the 
most unstable with a half-life of 10−9 seconds. Furthermore, ·OH has no specificity, as it reacts rapidly 
with almost any organic molecule. The lifetime of O2•− is also very short. O2•− can oxidize thiols to 
thiyl radical, but this reaction is too slow to be physically relevant. Although it was originally 
suggested that O2•− might play a role in cellular signalling, it is now thought that the signalling role of 
O2•− is more likely that of functioning as a precursor of H2O2. H2O2 is more stable, but it is rapidly 
metabolized either enzymatically by catalase and GSH peroxidase or non-enzymatically by low 
concentrations of transitional metals, such as iron. Thus, the levels of H2O2 in the cell are dependent on 
the concentration of the detoxification enzymes and the rate of H2O2 formation. The high diffusibility 
of H2O2 and its ability to target specific protein thiols, called reactive cysteine residues, makes H2O2 an 
effective second messenger [10]. 
The cysteine residues of proteins can be divided into four groups based
 
on their reactivity: those 
that form permanent structural
 
disulfide bonds, those that coordinate with metals, those that
 
remain in 
the reduced state and those that are susceptible
 
to reversible oxidation. Because the pKa of most 
protein Cys residues is 8.5 [11], the vast majority of cysteine residues of proteins exist in the reduced 
state as a Cys-SH at physiological or low pH (pH ≤ 7.2). The cysteine thiolate anion (Cys-S−) is 
readily and reversibly oxidized by H2O2, whereas the cysteine sulfhydryl group (Cys-SH) is not [12]. 
Protein cysteine residues can exist as thiolate anions at physiological pH, because the pKa values of 
these Cys residues are lowered due to the presence of nearby positively charged lysine or arginine 
amino acid residues. Under these conditions, a pKa of 6.5 is not uncommon. These special thiols are 
referred to as reactive cysteine residues, and these are specifically targeted by H2O2. As discussed, 
these reactive cysteine residues are strategically placed in many proteins and regulate the activity of 
the protein. The oxidation of reactive cysteine residues frequently results in the formation of an 
intramolecular disulfide bond with a second protein thiol. However, in the absence of a nearby second 
thiol, oxidation of the reactive cysteine leads to the formation of sulfenic acid (S-OH), S-nitrosothiols 
(S-NO) or S-glutathione (S-SG). These modifications are reversible and can be reduced back to the 
cysteine sulfhydryl group. Further oxidation leads to the irreversible formation of sulfinic acid (S-O2−) 
and sulfonic acid (SO3−2). Therefore, typically only sulfenic acids further form intra- or  
inter-molecular disulfide bonds (R-S-S-R) or mixed disulfide bonds with GSH (R-S-SG; called 
glutathionylation). Thus, the reaction of H2O2 with a reactive thiol results in the formation of sulfenic 
acid, which can then react with another Cys in the same or another protein, react with an amide in the 
backbone of the protein, react with GSH or become further oxidized to sulfinic acid. Interestingly, 
enzymes, called sulfiredoxins, have been shown to reduce sulfinic acids of certain proteins to  
sulfenic acids [13]. 
The primary thiol reductases, Trx and GSH, function as antioxidant proteins, which reduce the 
oxidized thiol groups of cellular proteins. Trx1 is a 12 kDa protein that regulates redox-sensitive 
signalling molecules and transcription factors and mediates redox-regulated gene expression. During 
reduction of target proteins, Trx1 is oxidized and subsequently reduced and regenerated by thioredoxin 
reductase and NADPH. The Trx1, Trx reductase and NADPH, collectively called the Trx redox 
system, constitute a key cellular antioxidant system [14]. GSH, a tripeptide (Glu-Cys-Gly), also acts as 
an antioxidant by forming a mixed disulfide with an oxidized thiol of the target protein. The GSH 
Int. J. Mol. Sci. 2013, 14 3571 
 
 
group is rapidly removed from target proteins by the enzyme glutaredoxin, thereby converting the 
oxidized cysteine residue of the target protein into a reduced cysteine [15]. In this regard, 
glutathionylation not only serves to protect protein cysteine residues from irreversible oxidation, but 
the incorporation of glutathione into the cysteine residue can also regulate protein activity and 
function. In addition to its role as an antioxidant, GSH also acts as a ROS scavenger. In the presence of 
the enzyme glutaredoxin, GSH reacts rapidly with H2O2 to form glutathione disulfide, thereby 
converting H2O2 to H2O. 
Normally, cells utilize transient increases in intracellular ROS levels as a mechanism to activate 
growth and proliferation. Increased intracellular ROS levels are a hallmark of many cancer cells and 
are thought to be partially caused by the constitutive activation of the NADPH-dependent oxidases 
early in the oncogenic conversion of normal cells to cancer cells. For example, oncogenic mutations in 
RAS genes, one of the most frequent mutations observed in cancer, cause the activation of NADPH 
oxidases and elevation in ROS levels. The increased ROS levels are tumourigenic by virtue of their 
ability to maintain cells in a proliferative state and to induce DNA damage, leading to carcinogenesis. 
Many reports have established that increases in ROS levels are directly correlated with tumour 
progression, angiogenesis and metastasis [16]. The constitutive oncogenic activation of NADPH 
oxidases requires that the cancer cell eliminate much of these ROS or risk accumulation of fatal 
cellular levels. To survive, cancer cells upregulate the proteins involved in ROS detoxification. For 
example, superoxide anions are converted to H2O2 and O2 by superoxide dismutase, whereas catalase, 
glutathione peroxidases and peroxiredoxins reduce H2O2 to water. Interestingly, ionizing or ultraviolet 
radiation, chemotherapeutic agents, such as etoposide, tamoxifen and doxorubicin, and other agents, 
such as Cr6+, kill cells in part by increasing intracellular levels of ROS. 
The essential elements of the GSH/GRx and Trx systems have been identified in the cytoplasmic 
and nuclear compartments, and it is now clear that cytoplasmic and nuclear redox compartments are 
independently regulated [15,17–19]. Furthermore, the selective generation of H2O2 in the nucleus also 
results in the increased glutathionylation of nuclear proteins [20]. Among the best characterized targets 
of H2O2 in the cytosol are PTEN and the protein tyrosine phosphatases (PTPs). H2O2 specifically 
oxidizes the catalytic cysteine residue of these enzymes and thereby inhibits their activity [21–23]. 
Since the activation of receptor protein tyrosine kinases (PTKs) by signalling molecules, such as 
growth factors, is insufficient to activate the protein tyrosine phosphorylation cascade in cells, because 
of the overwhelming resting levels of PTP activity, the concurrent inhibition of PTPs by H2O2 is 
required by many signal transduction pathways. H2O2 also targets the Trx-ASK-1(apoptosis activated 
protein kinase) complex, resulting in its dissociation, movement of ASK-1 kinase into the nucleus, 
activation of JNK/p38 MAPK and promotion of apoptosis [24,25]. In the nucleus, redox-dependent 
signalling mechanisms play a critical role in the regulation of gene expression. Many transcription 
factors, including AP1, Nrf2, NF-κB and p53, possess reversibly oxidizable cysteine residues in their 
DNA-binding domains, and oxidation of these cysteines blocks their DNA-binding activity [26,27]. 
Interestingly, redox factor-1 (Ref-1) reduces the oxidized cysteine residue of AP-1 using Trx1 as a 
reductant. Trx1 translocates into the nucleus in response to H2O2, tumour necrosis factor and ionizing 
radiation, where it maintains the critical reactive cysteine residues of transcription factors, such as  
Ref-1, in a reduced state [17,28].  
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Recent studies from our laboratory have identified the calcium- and phospholipid-binding protein, 
annexin A2, as a redox-sensitive protein that played an important role in cellular redox regulation and 
also functioned on the cell surface as a plasmin reductase. Annexin A2 was also identified by another 
group as one of nine high-abundance nuclear proteins that was oxidized after increasing nuclear ROS 
levels [29]. These studies, which have suggested important redox-related functions for annexin A2 on 
the cell surface, in the cytoplasm and in the nucleus, are discussed below.  
3. The Annexin Superfamily 
More than a thousand proteins in the eukaryotic phyla belong to the annexin superfamily, however 
annexins are absent from yeast and prokaryotes. Most eukaryotic species have 1–20 annexin genes. 
Annexins are commonly described as calcium-dependent phospholipid-binding proteins. The classical 
annexin core domain is made up of four similar repeats of approximately 70 amino acids long (I–IV) 
(except annexin A6, which has eight repeats). Each repeat is made up of five α helices (A-E), and the 
type II motif for binding of calcium ions (GxGT-38D/E) is usually located in the loop connecting the 
A–B helices. In addition to the type II calcium-binding sites, some annexins have type III calcium 
binding motifs typically located in the loop between helices D and E [30–32]. The N-terminus of the 
annexins is variable and is responsible for distinct localizations, specialized functions and, in some 
cases, ligand binding. Annexins are mainly localized in the membrane fraction with subpopulations 
present in the cytoplasm and other subpopulations that are stably or reversibly associated with 
components of the cytoskeleton. Some annexins bind to other proteins that mediate interactions 
between the cell and the extracellular matrix. Initially characterized as scaffolding and structural 
proteins due to their ability to bind to negatively charged phospholipids, increasing evidence has 
shown that annexins have a multitude of functions and are involved in a wide variety of cellular 
processes. The theory that annexins have fundamental, non-redundant functions is substantiated by the 
evolutionary conservation of 12 paralogous genes in humans and the ubiquity of annexins in a wide 
range of early eukaryotes, including plants and simple organisms, such as Hydra and Geodia [32]. 
The first annexin to be attributed to peroxidase activity was the plant annexin from  
Arabidopsis thaliana, AnnAt1 [33–35]. Historically, three studies using heterologous systems 
established that AnnAt1 could play a protective role during oxidative stress. First, recognition that 
AnnAt1 could protect cells from oxidative stress came from a study that used a mutant  
Escherichia coli (E. coli) strain that lacked the OxyR gene, a transcription factor that senses oxidative 
stress and is activated by the oxidation of its reactive cysteine residues. OxyR induces the transcription 
of the regulon of target genes encoding for different antioxidant proteins upon oxidative stress; thus, 
mutants lacking the oxyR gene are more sensitive to oxidative stress in comparison with wild-type  
E. coli. AnnAt1 was found to restore normal growth of this mutant strain in response to treatment with 
350 μM H2O2. It was suggested that this ability might be due to a catalase-like motif located at the  
N-terminus of AnnAt1, which had a conserved histidine residue (His40) that was predicted to be 
required for heme-binding. It was also shown that both bacterially-produced and immunoprecipitated 
AnnAt1 exhibited peroxidase activity in vitro. Second, a follow-up paper investigated the capability of 
AnnAt1 to protect human tumour cells from tumour necrosis factor (TNF)-induced cell death. TNF-α 
induces the activation of NADPH oxidase and consequent production of H2O2. Stable transfection of 
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AnnAt1 into a TNF-sensitive HeLa D98 cell line resulted in decreased levels of ROS and resistance to  
TNF-induced cell death. The authors also found that the transfected HeLa cells showed increased 
mRNA, protein and activity levels of the ROS-scavenging enzyme, manganese superoxide dismutase, 
which could explain the ROS buffering effect observed. A third study demonstrated that two different 
mammalian cell lines transfected with AnnAt1 were protected from H2O2-induced cell death. The 
transfected cells showed lower levels of O2•−, protein kinase C activity and tumourigenicity. Recently, 
it was shown that partially purified recombinant AnnAt1 contains low levels of peroxidase activity  
in vitro [36]. Nevertheless, this report showed that mutation of the His-40 residue to alanine (His-40-Ala) 
in the AnnAt1 protein did not block or even inhibit the peroxidase activity [36]. The ability of AnnAt1 
to complement the oxyR deletion mutant during oxidative stress was re-tested by this group, and they 
found that both AnnAt1 wild-type and AnnAt1 His-40-Ala mutant proteins could rescue the E. coli 
oxyR mutant upon H2O2 insult. All observations showing that AnnAt1 possesses an inherent 
peroxidase activity are based on assays using AnnAt1 purified with standard chromatography affinity 
methods to near homogeneity. It is therefore unclear if these protein preparations contain trace 
amounts of peroxidase(s) or if AnnAt1 actually has peroxidase activity. It is clear though that certain 
plant annexins provide oxidative protection to cells, as there are numerous cases where ectopic 
expression or overexpression of an annexin provided transgenic plants with abiotic stress resistance by 
reducing H2O2 and/or lipid peroxidation levels [36–40].  
It is clear that AnnAt1 is not a classical heme-binding peroxidase [34,36], so a possible alternative 
mechanism to explain this in vitro activity might be one similar to that found for annexin A2 and its 
binding partner, thioredoxin. Recently, our laboratory showed that annexin A2 functions as a redox 
regulatory protein [8]. This study provided evidence that the cysteine-8 residue of annexin A2 was 
selectively oxidized by H2O2 and then reduced by thioredoxin, thereby freeing the cysteine residue for 
further redox cycles. Thus, it is possible that AnnAt1 might interact with another antioxidant protein 
allowing the conserved cysteine residues to function in redox cycles, as we have proposed for annexin 
A2. Consistent with this possibility, a complex of proteins purified from Brassica rapa floral buds that 
has peroxidase activity contains AnnBr1 and a peroxiredoxin [41]. Recent studies applying a 
comparative proteomics approach to investigate the potential function(s) of annexin C4 from  
A. fumigatus revealed the downregulation of respiratory chain proteins and the upregulation of a 
number of stress response proteins in the annxC4 disruptant strain, suggesting the occurrence of a mild 
oxidative stress phenotype in the annxC4 disruptant strain [42]. This result suggested a possible 
oxidative stress response function for this fungus annexin. 
Annexin A2 can exist in the cells as a monomer or as a heterotetramer (AIIt), where two molecules 
of annexin A2 are linked by a dimer of the protein S100A10 [30,43,44]. S100A10 is a member of the 
S100 family of dimeric EF hand-type Ca2+-binding proteins. The S100 proteins are small, often acidic 
polypeptides of approximately 10 kDa, containing an N-terminal and a C-terminal EF hand separated 
by a rather unstructured linker region. S100A10 has amino acid mutations in the calcium-binding 
loops that have rendered these sites unable to bind calcium. However, these mutations have locked 
S100A10 in a calcium-on conformation. In contrast, all other members of the S100 family are  
Ca2+-regulated [45,46]. Annexin A2 is a planar, curved molecule with opposing convex and concave 
sides. The convex side of annexin A2 faces the cellular membrane and contains the Ca2+- and 
phospholipid-binding sites, whereas the concave side faces away from the membrane and contains 
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both the N- and C-terminal regions [30]. The N-terminus of annexin A2 contains the binding site for 
S100A10 [47], a reactive cysteine residue (Cys-8) [8,48,49], phosphorylation sites that are recognized 
by pp60src (Tyr-23) and protein kinase C (Ser-11, Ser-25) [50,51] and a nuclear export signal  
(NES) [52], while the C-terminal region contains a reactive cysteine residue (Cys-334) [53] and 
binding sites for F-actin, negatively charged phospholipids, fibrin, RNA and heparin [31,54–59]. 
Annexin A2 is unique among the vertebrate annexins in that it possesses an N-terminal reactive 
cysteine residue, Cys-8 (Figures 1 and 2). Interestingly, annexin A13, the progenitor annexin for the 
vertebrate family, may also possess a reactive cysteine, Cys-26, although this has not been confirmed 
experimentally. Annexin A13 is very limited in its tissue distribution, being expressed only in 
intestinal and kidney epithelial cells [60]. In contrast, annexin A2 is an abundant and ubiquitously 
expressed protein in cells and tissues. Annexin A2 is mainly localized in the cytoplasm and plasma 
membrane [61] with a small, but significant, population located in the nucleus [52,62,63]. Many 
functions have been attributed to annexin A2. Extracellular membrane associated AIIt was originally 
identified as a receptor for tenascin-C [64] and as a key plasminogen receptor at the surface of a large 
number of different cells, including macrophages, endothelial cells and cancer cells [46,65,66]. Cell 
surface AIIt also functions as a plasmin reductase, promoting the production of the angiostatin 
fragment, A61 [53]. Cytoplasmic AIIt has been suggested to be involved in endocytic and exocytic 
vesicular transport, interaction with cell adhesion molecules, regulation of ion channels, mediation of 
actin dynamics and to function as a scaffold protein in lipid raft organization [67]. One study reported 
that 15% of cellular annexin A2 was nuclear and was released from the nucleus by RNase A [62]. This 
is consistent with the report that annexin A2 binds to RNA [68]. Nuclear annexin A2 has also been 
suggested to play a role as part of a primer recognition protein complex that enhances DNA 
polymerase activity in vitro [69]. We have shown that annexin A2 accumulates in the nucleus in 
response to ROS-dependent stimulus and mitigates DNA damage [70]. Recently, our laboratory 
identified a novel function for annexin A2 as a cellular redox regulatory protein [8]. 
Figure 1. Comparison of the N-terminal domain of human annexins. The N-terminal 
domain of the known human annexins were compared using the open source software, 
Seaview (version 4.3.1) [71]. The N-terminal region of the annexins is unique and is 
responsible for conferring unique functional and regulatory properties to each annexin. The 
cysteine residues are highlighted in red boxes. The presence of a lysine residue next to a 
cysteine residue has been shown to lower the pKa of the cysteine residue, thereby 
converting it into a reactive thiol. The Cys-8 residue of annexin A2 has been shown to be a 
reactive thiol [8,48,49]. However, experimental work needs to be done to investigate the 
reactivity of annexin A13 Cys-26 residue.  
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Figure 2. The Cys-8 residue of annexin A2 is a reactive thiol. 293T cells were transiently 
transfected with pcDNA3 empty vector (lane 1), pcDNA3-ANXA2 WT (lane 2) or  
a series of ANXA2 cysteine mutant constructs, pcDNA3-ANXA2-Cys-8-Ala (lane 3),  
pcDNA3-ANXA2-Cys-8-Ser (lane 4), pcDNA3-ANXA2-Cys-132-Ala (lane 5) or 
pcDNA3-ANXA2-Cys-132-Ser (lane 6), for 48 h. 20 μg of each cell extract was labelled 
with 20 μM BIAM and subjected to SDS-PAGE, followed by Western blotting with a 
streptavidin probe (green) and the antibodies indicated: annexin A2 (red) and actin (grey). 
293T cells were chosen for these experiments, because of the very low levels of 
endogenous annexin A2. The data show that mutagenesis of Cys-8 of annexin A2 blocks 
the labelling of the protein by the reagent, BIAM. Since BIAM labels reactive thiols of 
proteins, these data establish that Cys-8 of annexin A2 is a reactive thiol.  
 
In this paper, we will carry out a comprehensive review of the studies detailing the reactivity of 
annexin A2 thiols and the importance of these reactive cysteine(s) in regulating annexin A2 structure 
and function. We will also focus on the recent reports that establish novel functions for annexin A2, 
namely as a protein reductase and as a cellular redox regulatory protein. We will further discuss the 
importance of annexin A2 redox regulatory function in disease, with a particular focus on  
tumour progression.  
4. Annexin A2 Cysteine Reactivity and Functional Implications 
Several studies using a number of different approaches have established that annexin A2 possesses 
reactive cysteine residues. Historically, the first report that demonstrated the post-translational 
modification of a cysteine residue of annexin A2 utilized electrospray ionization mass spectrometry to 
show that Cys-8 residue of annexin A2 could form a disulfide bond with homocysteine in vitro [72]. 
The authors claimed that binding of homocysteine to Cys-8 of annexin A2 interfered with the 
interaction between tissue-type plasminogen activator (tPA) and annexin A2 [72]. Homocysteine 
(Hcy) is a thiol-containing amino acid that is an intermediate product in the methionine conservation 
cycle and in the one-carbon metabolic and trans-sulfuration pathways. 70%–80% of Hcy is bound to 
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protein cysteine residues via a thiol disulfide exchange reaction [73]. The proposed role for Cys-8 of 
annexin A2 as a binding residue for tPA is controversial. tPA binding to the cell surface has been 
shown by other laboratories to share a common binding site with plasminogen in vivo [46]. Other 
studies showed that tPA binding to the cell surface was blocked by lysine analogs, such as 
aminocaproic acid, and was inhibited by 89% by carboxypeptidase B treatment (which removes  
C-terminal lysine residues) [46]. Therefore, a number of studies have supported the concept that both 
tPA and plasminogen share binding sites on the cell surface and that these binding sites are C-terminal 
lysines of cellular plasminogen receptors. Furthermore, binding of tPA to Cys-8 of annexin A2 
through the formation of a disulfide bond contradicts the multiple reports that have rigorously analysed 
the interaction of tPA with the cell surface and concluded that tPA interacts reversibly with its cell 
surface receptor(s) [74–76]. A more recent study showed that a number of different peptides 
containing substitutions of the amino acids in the vicinity of Cys-8 of annexin A2 form a disulfide 
bond with the annexin A2 Cys-8 residue, but not with tPA [77]. These authors demonstrated that a 
hexapeptide constituted by amino acids 7–12 of annexin A2, including the Cys-8 residue, did not bind 
to tPA [77]. This finding further supports that the Cys-8 residue of annexin A2 is a reactive thiol, but 
not a binding site for tPA. 
Another study reported that treatment of AIIt with N-ethylmaleimide (NEM), a sulfhydryl reagent 
that binds to reactive cysteine residues at physiological or low pH (pH ≤ 7.2), resulted in the labelling 
of AIIt with NEM in vitro. Labelling of AIIt with NEM rendered this protein complex unable to 
mediate liposome aggregation in vitro. Nevertheless, NEM-treated AIIt was still able to bind to 
negatively charged phospholipids [78]. Even though this report showed that AIIt contains reactive 
cysteine(s), the authors did not investigate which cysteine residue(s) of annexin A2 and/ or S100A10 
were modified by NEM. 
TNF-α induces the production of ROS by several mechanisms. Many reports have shown that  
TNF-α signalling upregulates the transcription of various NADPH oxidase components, such as Nox2, 
Nox3, Nox4, p22phox, p47phox, NOXO1 and p67phox [79–86], which contribute to oxidase activity. 
Other mechanisms for potentiation of superoxide production by TNF-α have been proposed, such as 
the phosphorylation of p47phox by downstream kinases, including PKCzeta [87], tyrosine  
kinases [88–90] and p38 MAPK [91]. TNF-α has also been suggested to regulate NADPH oxidase 
activity through regulation of the associated hydrogen ion channels [92]. More recently, it was shown 
that TNF-α is a direct activator of NADPH oxidases in various cell types [93]. The first study that 
demonstrated the presence of a reactive cysteine residue in vivo was reported by Sullivan et al., who 
identified annexin A2 and the antioxidant protein, thioredoxin peroxidase II, as the major proteins 
glutathionylated in HT1080 cells upon TNF-α treatment. These studies utilized a novel approach, 
namely the use of biotinylated glutathione analogue, BioGEE, to tag glutathionylated proteins with 
biotin [48]. They also found that H2O2 treatment of HeLa cells led to increased incorporation of the 
BioGEE label into annexin A2. The authors identified Cys-8 residue of annexin A2 as the target for 
glutathionylation in vivo. In a subsequent study, our laboratory also showed that exposure of HT1080 
cells to H2O2 enhanced the incorporation of BioGEE into annexin A2, further supporting that annexin 
A2 was S-glutathionylated upon oxidative stress [49]. Treatment of AIIt with the thiol-specific 
oxidant, diamide, resulted in a time- and concentration-dependent loss of the ability of AIIt to 
aggregate and interact with phospholipid liposomes and F-actin, which was partially reversed by 
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dithiothreitol (DTT), suggesting that AIIt oxidation was responsible for this inhibitory effect. In 
addition, incubation of AIIt with diamide and GSH resulted in the glutathionylation of AIIt in vitro. 
Mass spectrometry established the incorporation of 2 mol of GSH/mol of annexin A2 subunit at  
Cys-8 and Cys-132 in vitro, whereas the S100A10 subunit of AIIt was not glutathionylated. 
Glutathionylation of annexin A2 blocked the ability of AIIt to bind to and aggregate liposomes and to 
interact with and bundle F-actin in vitro. We also showed that annexin A2 could undergo functional 
reactivation by glutaredoxin, which established that annexin A2 can be reversibly glutathionylated [49]. 
The Sullivan study is in agreement with our more recent results that show that Cys-8 residue of 
annexin A2 is the reactive cysteine residue in vivo, since mutation of Cys-8 to alanine or serine leaves 
this protein unable to react with the biotinylated iodoacetamide derivative, BIAM [8] (Figure 2). Since 
the oxidation of the thiolate to a sulfenic acid must occur before a thiol can react with glutathione, 
Cys-132 may be responsive to oxidation agents, according to the conformation of annexin A2 [15]. 
Nitric oxide also regulates protein function by covalent attachment of the NO group to cysteine 
thiolate residues in proteins via S-nitrosylation. Liu et al. have shown that incubation of AIIt with  
S-nitrosoglutathione (GSNO) led to the inhibition of AIIt-mediated liposome aggregation in a  
dose-dependent manner [94]. Sodium nitroprusside, another NO donor, also inhibited AIIt-mediated 
liposome aggregation, whereas GSH, nitrate or nitrite had no effects. Glutathionylation of cysteine 
residue(s) of annexin A2 has been clearly documented in Sullivan’s and Caplan’s reports; since Liu 
and colleagues did not investigate if the GSH used reacted with annexin A2, it is difficult to interpret 
their result showing lack of inhibition of liposome aggregation in GSH treated AIIt samples. GSNO 
also inhibited AIIt-mediated membrane fusion, but not the binding of AIIt to the membrane [94]. 
GSNO inhibition of annexin II-mediated liposome aggregation was no longer observed in the presence 
of dithiothreitol (DTT), suggesting that inhibition of annexin II activity by GSNO was achieved 
through S-transnitrosylation and/or the formation of disulfide bond(s) [94]. 
5. The Role of Annexin A2 As a Plasmin Reductase 
Our laboratory showed for the first time that the reactive cysteine residues of AIIt have reductase 
activity, establishing that these thiols are not only important for the regulation of certain properties and 
functions of AIIt, but also exert a functional activity of their own within this protein complex [53,95]. 
The reagent, 3-(N-maleimidopropionyl) biocytin (MPB), which reacts with free sulfhydryl containing 
proteins, was used in order to follow plasmin reduction and AIIt oxidation. Plasminogen and plasmin 
do not possess free sulfhydryl groups and, for this reason, cannot be labelled by MPB; reduction of 
plasmin results in the formation of new sulfhydryl groups that can be detected by MPB labelling. 
Using this approach, we showed that AIIt could reduce plasmin disulfide bonds in vitro and that the 
cysteine residues of annexin A2 and its binding partner, S100A10, participated in the reduction of 
plasmin. This study established that AIIt and annexin A2 monomer possess intrinsic plasmin reductase 
activity. AIIt stimulated the reduction of the plasmin Cys-462-Cys-541 bond in a time- and 
concentration-dependent manner, which resulted in the release of a plasmin fragment (Lys-78-Lys-468), 
called angiostatin (A61). Mutagenesis of annexin A2 Cys-334-Ser and either S100A10 Cys-61-Ser or 
S100A10 Cys-82-Ser inactivated the plasmin reductase activity of the isolated subunits of AIIt, 
suggesting that these cysteine residues directly participated in the plasmin reductase activity of each 
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subunit. Furthermore, loss of AIIt from the cell surface of HT1080 cells transduced with a retroviral 
vector encoding S100A10 antisense dramatically reduced the cellular production of A61 from 
plasminogen. This result indicates that AIIt might play a main role not only in plasminogen activation, 
but also in plasmin inactivation at the cell surface, tightly regulating the activity of this serine protease.  
We also investigated the oxidative status of AIIt during plasmin reduction. We showed that 
incubation of HT1080 cells with plasminogen resulted in the rapid loss of thiol-specific labelling of 
AIIt by MPB. Since Cys-334 of annexin A2 is not available to the MPB label [53], it is unclear which 
cysteine residue of annexin A2 becomes oxidized during plasmin reduction. The most likely candidate 
seems to be Cys-8 of annexin A2, because it is exposed to the solvent and has been shown to react 
with MPB. In fact, the Cys-8-Ser mutant of annexin A2 cannot be labelled by MPB, indicating that 
Cys-8 residue of annexin A2 is the only thiol that is available for MPB labelling [53]. Nevertheless, 
mutation of Cys-8 of annexin A2 revealed that this residue does not directly contribute to annexin A2 
plasmin reductase function. Also, treatment of AIIt with iodoacetamide or MPB resulted in a very 
small decrease in the plasmin reductase activity of AIIt. One explanation for this result is that Cys-8 of 
annexin A2 might reduce the Cys-334 residue that becomes oxidized by plasmin, thereby resulting in 
the oxidation of the Cys-8 residue. Another possible explanation is that Cys-334 of annexin A2 is only 
exposed to the solvent and, consequently, available for MPB labelling after annexin A2/AIIt binding to 
plasmin. More work needs to be done to investigate these hypotheses.  
We further investigated if oxidized AIIt could be subsequently reduced and, in this way, recover its 
protein reductase function. Several reductants were examined, but only thioredoxin could prevent 
plasmin dependent oxidation of AIIt, whereas protein-disulfide isomerase, glutathione, cysteine and 
phosphoglycerate kinase did not reduce AIIt [95]. Future studies are necessary to establish which 
cysteine residues of AIIt are substrates for thioredoxin reduction. We also performed a comparative 
study of AIIt with other well-established plasmin reductases. These results showed that AIIt was a 
more potent plasmin reductase compared to protein disulfide isomerase, thioredoxin and 
phosphoglycerate kinase under our experimental conditions in vitro [53].  
Taken together, these studies allowed us to propose the following mechanism for the plasmin 
reductase activity of AIIt (Figure 3). Plasminogen binds to the S100A10 subunit of AIIt and is 
converted to plasmin by uPA or tPA through the cleavage of the Arg-561-Val-562 bond of 
plasminogen. Plasmin then catalyzes the autoproteolysis of the Lys-77-Lys-78 and Lys-468-Gly-469 
bonds. However, the presence of a Cys-462-Cys-541 disulfide prevents release of angiostatin, A61 
(Lys-78-Lys-468), from plasmin. AIIt catalyzes the reduction of the Cys-462-Cys-541 disulfide, which 
allows the release of A61 from the rest of the molecule. Plasmin autoproteolysis must occur prior to its 
reduction, since AIIt is not able to reduce catalytically inactive plasmin [53,95]. This suggests that 
autoproteolyzed plasmin is the substrate for the AIIt. The thioredoxin system then reduces AIIt, 
enabling it to exert again its protein reductase activity. 
More recently, we observed that annexin A2-depleted cells show enhanced oxidation of the annexin 
A2 binding partner actin and also of the oxidative stress response transcription factor, JunD, upon 
oxidative damage [8]. These results suggest that annexin A2 and/or AIIt might also function as protein 
reductase(s) inside the cells. Further studies are necessary in order to investigate this hypothesis. 
Int. J. Mol. Sci. 2013, 14 3579 
 
 
Figure 3. Molecular model for AIIt plasmin reductase function. Plasmin catalyzes the 
autoproteolysis of the Lys-77-Lys-78 and Lys-468-Gly-469 bonds. AIIt catalyzes the 
reduction of the Cys-462-Cys-541 disulfide of plasmin, allowing the release of  
angiostatin, A61.  
 
6. The Role of Annexin A2 As a Cellular Redox Regulatory Protein 
Recently, our laboratory identified annexin A2 as a novel cellular redox regulatory protein that 
played a significant protective role in cells undergoing oxidative stress and, in particular,  
during tumourigenesis.  
We showed for the first time that Cys-8 residue of annexin A2 is reversibly oxidized by H2O2 and 
reduced by the thioredoxin system in vitro [8]. Our results allowed us to propose the following 
mechanistic model: H2O2 reacts with the Cys-8 of annexin A2, resulting in the oxidation of this residue 
and the conversion of H2O2 to H2O. Oxidized annexin A2 is then reduced by the Trx redox system and 
can participate in multiple redox cycles (Figure 4). Thus, a single molecule of annexin A2 has the 
ability to degrade several molecules of H2O2. 
As mentioned earlier in this review, H2O2 is an important second messenger in cellular signal 
transduction that regulates many cellular processes, such as proliferation, differentiation, migration and 
apoptosis. A tight control in the levels of cellular H2O2 is then very important for cell signalling 
regulation and also to avoid protein, lipid and DNA oxidative damage. We showed that annexin  
A2-depleted cells exhibit significantly higher levels of ROS and increased oxidation of redox sensitive 
proteins upon treatment with exogenous H2O2, as compared to control cells. We also verified that 
depletion of annexin A2 did not alter the expression levels of the main known antioxidant proteins. 
This result, together with the ability of H2O2 to directly oxidize the Cys-8 residue of annexin A2, 
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indicated that it is the annexin A2 redox regulatory function that is responsible for the ROS buffering 
effect observed in oxidative stressed cells. We observed enhanced activation of the pro-apoptotic 
kinases p38, JNK and Akt in the annexin A2-depleted cancer cells treated with H2O2 compared to 
control cells; these protein kinases serve as reporters for the activity of the Ask-1 and PI3K signalling 
pathways, respectively. The Ask-1 signalling pathway is the major intracellular sensor of oxidative 
stress induced by H2O2. Even though the PI3K pathway is usually associated with cell survival, it has 
been shown that under oxidative stress conditions, Akt further increases the intracellular levels of ROS 
through an increase in oxygen consumption and inhibition of FoxO transcription factors, thereby 
sensitizing cells to ROS-mediated apoptosis [96]. Thus, the oxidative stress responsive pathways are 
more activated in the annexin A2-depleted cells compared to the control cells, most likely due to the 
higher levels of ROS existent in these cells. This also provides a molecular mechanism that explains 
the increased sensitivity of the annexin A2-depleted cells to ROS-induced death. 
We also showed increased sensitivity of the annexin A2-depleted cells to death induced by 
chemotherapeutics that increase intracellular ROS levels. Several reports have previously shown that 
upregulation of annexin A2 in tumours correlates with chemoresistance, but they were unable to 
explain the mechanism(s) by which this occurs. Our results provided an explanation for this 
observation, since annexin A2 antioxidant function will protect the cancer cells from oxidative 
damage/death induced by the chemotherapeutic agents.  
The development of an annexin A2 knockout mouse model allowed us to analyse the possible redox 
function(s) of annexin A2 in the mouse tissues. These experiments showed that annexin A2 knockout 
mice have enhanced liver and lung protein oxidation compared to wild-type mice. Liver cells have a 
high metabolic rate, since this organ is involved in protein, lipid and carbohydrate metabolism, 
synthesis of urea and the manufacture of bile, factors that result in increased ROS production by the 
mitochondria of the liver. The lung is constantly exposed to oxidative stress due to gas exchange 
between the alveoli and the red blood cells. Therefore, liver and lung are continually exposed to 
oxidative stress. Our results showing the presence of high levels of oxidized proteins in the lung and 
liver tissues of the annexin A2 knockout mouse supported an important cellular redox regulatory role 
for annexin A2 in vivo. However, it was unclear if annexin A2 directly participated in the reduction of 
oxidized cellular proteins or functioned to prevent the accumulation of ROS in these tissues. 
One might expect that if annexin A2 played a key role in cellular redox, the annexin A2 knockout 
mice should show a more extreme phenotype. However, considering the importance of cellular redox 
regulation, it is not surprising that cells possess redox proteins with redundant functions. For instance, 
homozygous catalase knockout mice, which are completely deficient in catalase expression, the major 
cellular enzyme that decomposes H2O2, develop normally and show no gross abnormalities under 
physiological conditions. In fact, mice deficient in catalase were not more vulnerable to  
hyperoxia-induced lung injury; nor did their lenses show any increased susceptibility to oxidative 
stress generated by photochemical reaction, suggesting that the antioxidant function of catalase in 
these two models of oxidative injury is either negligible, which is very unlikely, or is compensated by 
other cellular antioxidant protein(s) [97]. The only phenotype observed in these knockout mice was a 
retarded rate in decomposing extracellular H2O2 by the liver, lung and lens tissue slices compared to 
the wild-type mice. This phenotype is comparable with what we observed for the annexin A2 knockout 
mice, even though two different approaches to measure oxidative stress were used.  
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Figure 4. Molecular model for the H2O2 buffering function of annexin A2. H2O2 oxidizes 
Cys-8 of annexin A2, resulting in its conversion to H2O and O2. Oxidized annexin A2 is 
then reduced by the Trx redox system and can participate in multiple redox cycles. Thus, a 
single molecule of annexin A2 can degrade several molecules of H2O2. 
 
7. Annexin A2 Redox Status and Function in Disease 
The importance of annexin A2 redox status and regulatory function in disease remains poorly 
understood. Recent studies have shown changes in the redox status of annexin A2 under oxidative 
stress conditions, including cancer. Several proteomic studies that examined changes in the redox 
status of cellular proteins after treatment with a variety of oxidative stress-inducing agents have 
identified annexin A2 as a redox sensitive protein.  
Jones’s laboratory initially showed that nuclear annexin A2 becomes oxidized in response to 
oxidative stress [29]. These authors developed a methodology to study oxidation of specific cysteines 
in high-abundance nuclear proteins. The technique used heavy (13C) and light (12C) forms of  
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biotin-labelled iodoacetamide to quantify the redox state of nuclear proteins in response to oxidative 
stress caused by treatment of cells with glucose/glucose oxidase (Glc/Glc oxidase) to generate H2O2 at 
a physiological level. The authors isolated the nucleus of these cells and analysed the catalogue of 
nuclear proteins that responded to oxidative stress. Of the nine high abundance nuclear proteins that 
were identified in this analysis, annexin A2 showed the most dramatic increase in cysteine oxidation. 
Respiratory Syncytial Virus (RSV) infection increases ROS production in epithelial cells by 
activating NADPH oxidase, while downregulating cytoplasmic catalase and superoxide dismutase [98]. 
A proteomics study showed a 2.3-fold increase in annexin A2 protein levels in the nucleus of A549 
cancer cells infected with RSV compared to uninfected cells [99]. Peroxiredoxin I (PRDX I) and 
PRDX IV knockdown led to enhanced levels of ROS in the A549 cells and oxidation of cysteine 
residue(s) in nuclear annexin A2. Unfortunately, the non-nuclear fraction was not analyzed. The 
authors concluded that the peroxiredoxins protect annexin A2 from oxidation. Nevertheless, it is 
unclear if annexin A2 and the peroxiredoxins act together in cellular ROS buffering, and depleting the 
cells from PRDX I and PRDX IV resulted in overwhelming the remaining redox regulatory systems, 
thereby resulting in the oxidation of annexin A2. Another study showed that peptidyl-prolyl cis-trans 
isomerase A, protein disulfide isomerase A(3) (ERp57), serpin B3, annexin A2 and GAPDH were  
less oxidized in human papillomavirus (HPV)-driven carcinoma samples compared to dysplastic  
tissues [100]. HPV16 neoplastic progression is associated with an increased oxidant environment. In 
dysplastic tissues, the oxidative modification of DNA and proteins involved in cell morphogenesis and 
terminal differentiation may provide the conditions for the neoplastic progression. Conversely, cancer 
tissues seem to have an improved regulation of oxidative damage, as shown by the selective reduction 
of carbonyl adducts on key detoxifying/pro-survival proteins. The fact that annexin A2 was one of the 
five proteins that were less oxidized in the cancer tissues [100] suggests that it might play a main role 
in ROS detoxification in this cancer type. Nevertheless, this is a hypothesis that needs to be  
further investigated. 
Several studies have also shown an increase in annexin A2 levels upon treatment of cells with 
exogenous H2O2- or ROS-producing agents. Ferric nitrilotriacetate (Fe-NTA) induces oxidative renal 
damage, a consequence of a Fenton-like reaction in vivo, leading to a high incidence of renal cell 
carcinoma (RCC) in rats. Differential display analysis of RCCs showed elevated expression of annexin 
A2 [101]. Depletion of annexin A2 in Fe-NTA-induced RCC cell lines resulted in apoptosis [101], 
suggesting that the ROS buffering function of annexin A2 might play an important role in this cancer 
cell model. The authors showed a time-dependent upregulation of annexin A2 protein and mRNA 
levels in rat kidney after Fe-NTA administration, as well as in H2O2 treated LLC-PK1 cells. The later 
was inhibited by pre-treatment with the antioxidants, NAC, pyrrolidine dithiocarbamate or catalase. It 
was concluded that annexin A2 expression is regulated by the cellular redox status, but the authors did 
not investigate if annexin A2 had a redox regulatory function in these cells. Another report used a  
gel-based proteomics approach in order to investigate if senescent human mesenchymal stem cells 
(hMSCs) established by incubation with a sub-lethal concentration of H2O2 (150 µM) are differentially 
regulated compared to control hMSCs [102]. Annexin A2 and myosin light chain 2 were the only 
proteins upregulated in oxidative stress-induced senescent hMSCs. The protein and gene expression 
levels of annexin A2 increased significantly in H2O2-induced senescent hMSCs compared to control 
hMSCs, as confirmed by Western blotting and RT-PCR, validating the results obtained by the 2-DE 
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analysis. Our laboratory showed a two-fold increase in annexin A2 levels after treatment of 293T and 
MCF7 cells with 100 μM H2O2 [8]. These results suggest that cells might respond to elevations in ROS 
levels/oxidative stress by inducing the expression of annexin A2.  
One study investigated the effect of the Mongolian remedy RuXian-I in the treatment of breast 
hyperplasia [103]. Rats were either mock treated (control group), injected with estradiol and 
progesterone to induce breast hyperplasia (model group) or treated with RuXian-I after induction of 
breast hyperplasia. Subsequently, the authors used an approach that integrated size-based 2D-DIGE, 
MALDITOF/TOF-MS and bioinformatics to analyze data from the control group, the model group and 
the RuXian-I-treated group. Fifteen proteins were upregulated, including annexin A2, annexin A1, 
superoxide dismutase [Mn], peroxiredoxin-1, translationally-controlled tumour protein and  
α B-crystallin in the model group compared to the control group and downregulated upon treatment 
with RuXian-I [103]. Multiple biological activities have been reported for the main components of 
RuXian-I. For example, Herba Leonuri japonici has anti-inflammatory and antioxidant activity, 
suppresses oxidative stress and ameliorates hypercholesterolemia activity. This result suggests that 
downregulation of ROS levels in the cells decreases annexin A2 protein levels. Nevertheless, this is a 
very speculative interpretation, since this remedy is composed of several different compounds with 
diverse properties. 
Ex vivo experiments using human colon and gastric samples showed that the majority of tumours 
had enhanced levels of the reduced form of annexin A2 compared to normal tissue, whereas the 
tumour samples that did not show upregulation of the reduced form of annexin A2 had significantly 
higher levels of total protein oxidation [8]. These results indicate that annexin A2 antioxidant function 
is important for the maintenance of the cellular redox equilibrium in human tumours, since, in general, 
tumours show elevated levels of reduced annexin A2, and loss of reduced annexin A2 led to increased 
protein oxidation/oxidative stress. 
8. Annexin A2 Cellular Redox Regulatory Function Supports Tumour Growth 
During tumourigenesis, cancer cells typically exhibit enhanced ROS levels. In order to balance the 
proliferative advantages of ROS upregulation versus its potential risks due to protein, lipid and DNA 
damage, cancer cells induce the overexpression and/or activation of redox regulatory proteins. 
Recently, we analysed the role played by annexin A2 in tumour growth [8]. We showed that the 
growth of tumours initiated by the subcutaneous injection of annexin A2-depleted cancer cells was 
severely impaired compared to tumours initiated with control cancer cells. However, the growth 
impairment of the annexin A2-depleted tumours could be rescued by the administration of the 
antioxidant compound, N-acetyl cysteine (NAC), in the mice [8]. The tumours formed from annexin 
A2-depleted cancer cells also showed significantly enhanced protein oxidation (sensor for cellular 
oxidative damage) compared to tumours initiated with control cancer cells. Nevertheless, there was no 
significant difference in protein oxidation levels in the annexin A2-depleted tumours compared to 
control tumours when the mice received NAC [8]. Taken together, these results indicate that annexin 
A2 depletion resulted in a loss of cellular redox regulatory capability, which became critical as these 
cancer cells were subjected to enhanced oxidative stress in the tumour site in vivo.  
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It was interesting to observe that NAC by itself stimulated tumour growth of the control cancer 
cells. This result is consistent with the reports that, compared to normal cells, cancer cells are under 
significant oxidative stress and that agents that increase cellular ROS levels can selectively kill cancer 
cells [104,105]. In this situation, NAC can act by lowering the levels of H2O2 in the tumours, thus 
increasing cell proliferation or decreasing cell death. This result also indicates that oxidative stress 
played a major role and is a limiting step in tumour growth under our experimental conditions.  
Annexin A2 in its heterotetrameric form, AIIt, has also been implicated in other cellular processes, 
in particular, plasmin activation, which could also contribute to cancer progression [46]. In this regard, 
it has been shown that S100A10 acts as the plasminogen receptor, whereas annexin A2 functions to 
anchor S100A10 to the cell surface [45,46,106]. Several studies have shown that plasmin activation 
does not play a major role in the subcutaneous growth of primary tumours [107,108]. More 
importantly, plasmin generation by AIIt or other plasminogen receptors is not regulated by NAC, but 
is dependent on the presentation of a C-terminal lysine residue by the plasminogen receptor [45,95,109]. 
Consequently, if the growth deficit observed in the annexin A2-depleted tumours was due to decreased 
plasmin activation, the addition of NAC would not have reversed the phenotype and restored the 
growth of annexin A2-depleted tumours, as observed. 
Several reports have shown that upregulation of annexin A2 levels is positively associated with 
cancer progression [110] and chemoresistance [111,112]. Nevertheless, the function of annexin A2 
during these processes remained unknown. Our laboratory has proposed a molecular mechanism by 
which annexin A2 contributes to tumourigenesis and resistance to chemotherapy, by acting as a 
cellular redox regulatory protein. Development of strategies that are aimed at preferentially killing 
cancer cells through mechanisms that cause additional ROS overload are currently being used. Agents 
that block annexin A2 expression could therefore be useful to preferentially kill malignant cells. 
9. Annexin A2 Nuclear Translocation and Protection of DNA from Oxidative Damage 
Our laboratory recently showed that genotoxic agents, such as IR, UV-A, etoposide, Cr6+ and also 
H2O2, promote annexin A2 nuclear accumulation in a ROS-dependent manner, since pre-treatment of 
cells with NAC prevented the nuclear accumulation of annexin A2. We showed that a  
GFP fusion protein consisting of the annexin A2 NES fused to the N-terminus of GFP  
(1STVHEILCKLSLEGD15-GFP) was excluded from the nucleus in mock treated cells, but 
accumulated in the nucleus in response to H2O2 [70]. This result suggested that the nuclear 
accumulation of annexin A2 is most likely regulated by its NES. Since the nuclear accumulation of 
annexin A2 was blocked by the antioxidant NAC and stimulated by H2O2, we suspected that oxidation 
of Cys-8 within the NES might inactivate the NES and promote the nuclear accumulation of annexin 
A2 by preventing the export of the nuclear protein. However, the GFP fusion protein 
(1STVHEILAKLSLEGD15-GFP), consisting of GFP fused to the N-terminal region of annexin A2, 
which had a Cys-8-Ala mutation, was excluded from the nucleus in non-treated cells and also 
accumulated in the nucleus in response to H2O2 [70]. This result suggested that the redox status of the 
Cys-8 residue of annexin A2 does not regulate the NES. We also showed that the annexin A2 binding 
partner, S100A10, did not accumulate in the nucleus in response to genotoxic agents [70], which was 
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in accordance with a previous study that reported that monomeric annexin A2 accumulated in the 
nucleus in response to LmB treatment [52].  
Other annexins have been shown to accumulate in the nucleus in response to oxidative stress. Plant 
AnnAt1, as most annexins, does not possess a nuclear localization sequence. However, translocation of 
AnnAt1 to the nucleus has been observed upon stress stimulation [32,113–116]. Similarly, treatment 
of cells with H2O2 has been shown to cause the translocation of mammalian annexin A1 from the 
cytoplasm to the nucleus [33]. A more recent report has also shown the nuclear translocation of 
annexin A2 upon treatment of cells with X-radiation [117]. Even though the authors observed 
increased sensitivity of annexin A2-depleted cells to TNF-α-induced cell death [117], they did not 
investigate if this was due to annexin A2 cellular redox regulatory function.  
The fact that annexin A2 accumulates in the nucleus in response to DNA damaging agents led us to 
hypothesize that annexin A2 might play a role in protecting DNA from oxidation by ROS. Genotoxic 
agents are known to directly interact with DNA, causing strand breaks. The rapid phosphorylation of 
histone H2AX at serine 139 is a sensitive marker for DNA double-strand breaks induced by IR or 
other genotoxic agents [118]. Interestingly, we observed that treatment of cells with IR or H2O2 
resulted in significantly higher levels of P-H2AX in the annexin A2-depleted cells compared to control 
cells. The tumour suppressor p53 protein accumulates in the nucleus upon DNA damage, where it 
functions as a transcription factor regulating cell cycle arrest/apoptosis [119–121]. We observed that 
annexin A2-depleted cells have increased p53 accumulation upon IR treatment compared to control 
cells. Several proteins involved in DNA repair and DNA damage signalling, such as phosphorylated 
histone 2A family member X (γ-H2AX) and the tumour suppressor p53 binding protein 1 (53BP1), 
have been shown to produce discrete foci that co-localise to DNA strand breaks [122,123]. We showed 
that annexin A2-depleted cells formed significantly more 53BP1 foci after H2O2 and IR exposure 
compared to control cells. These results taken together indicate that annexin A2 plays a role in 
protecting DNA from genotoxic damage. Since the mechanism(s) of damage and repair for the 
different genotoxic agents investigated were distinct, the most likely mechanism by which annexin A2 
mitigates DNA damage would be through its redox regulatory function. Genotoxic agents, such as IR, 
can cause oxidative damage to DNA, which results in the formation of 7,8-dihydro-8-oxo-2'-deoxyguanine 
(8-oxo-G) base mutations in the DNA [124]. We observed that cells depleted of annexin A2 had more 
oxidative DNA damage than control cells in response to IR, as measured by the presence of 8-oxo-G, 
supporting the hypothesis that annexin A2 redox regulatory function is important for its ability to 
protect cellular DNA from oxidative damage. 
10. Conclusions and Future Directions 
The presence of reactive cysteine residues in annexin A2 has been known for many years. However, 
the recent demonstration by our laboratory of the reversible oxidation of Cys-8 of annexin A2 by H2O2 
and the reversible glutathionylation of this residue has suggested that annexin A2 plays a key role in 
cellular redox regulation. The exact role that Cys-8 plays in the physiological functions of annexin A2 
is unclear, but is under intense investigation. Since extracellular annexin A2 can act as a plasmin 
reductase, it is possible that annexin A2 may function intracellularly to reduce oxidized proteins. It is 
also possible that some or all of the functions attributed to annexin A2, such as its role in endocytosis, 
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exocytosis and regulation of ion channels or possibly the transport of dopamine receptors to the cell 
surface, may be regulated by its redox status. It is also imperative to establish if annexin A2 protein 
cysteine oxidation by H2O2 is rapid enough to be relevant for cell signalling. Kinetic studies are 
necessary to establish the rate at which annexin A2 can detoxify H2O2 and evaluate its role in the direct 
regulation of H2O2 levels in the cells under normal conditions or during oxidative stress. Therefore, 
future studies will be necessary to establish if the reactive cysteine residue(s) of annexin A2 function 
as a peroxidase by directly interacting with ROS or by acting as a redox sensor and regulating other 
proteins and/or peroxidases. The reactive cysteines of annexin A2 could function to regulate the 
interaction of annexin A2 with other cellular structures, such as the lipid rafts or the cytoskeleton. 
Previous studies demonstrating the role of annexin A2 in processes, including exocytosis, endocytosis, 
the regulation of the cytoskeleton and membrane organization and ion conductance, coupled with our 
studies identifying annexin A2 as a redox protein, open up many exciting possibilities for the function 
of this pleiotropic protein. 
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